{"id":"https://openalex.org/W7225570629","doi":"https://doi.org/10.1161/circ.154.suppl_1.7110","title":"Abstract 7110: Cerebrovascular Safety Profile of Edoxaban versus Rivaroxaban: A Global Pharmacovigilance Analysis with Implications for Asian Populations","display_name":"Abstract 7110: Cerebrovascular Safety Profile of Edoxaban versus Rivaroxaban: A Global Pharmacovigilance Analysis with Implications for Asian Populations","publication_year":2026,"publication_date":"2026-11-02","ids":{"openalex":"https://openalex.org/W7225570629","doi":"https://doi.org/10.1161/circ.154.suppl_1.7110"},"language":"en","primary_location":{"id":"doi:10.1161/circ.154.suppl_1.7110","doi":"https://doi.org/10.1161/circ.154.suppl_1.7110","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circ.154.suppl_1.7110","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053900653","display_name":"Ratnadeep Biswas","orcid":"https://orcid.org/0000-0001-7136-4459","observed_orcids":["https://orcid.org/0000-0001-7136-4459"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ratnadeep Biswas","raw_affiliation_strings":["ESIC Med College & Hosp, Bihta, Patna, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ESIC Med College & Hosp, Bihta, Patna, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161284148","display_name":"VISHNU OJHA","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I17972996","display_name":"Vardhman Mahavir Medical College & Safdarjung Hospital","ror":"https://ror.org/03zj0ps89","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I17972996"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"VISHNU OJHA","raw_affiliation_strings":["Vardhman Mahavir Med College & Safdarjung Hosp, New Delhi, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vardhman Mahavir Med College & Safdarjung Hosp, New Delhi, India","institution_ids":["https://openalex.org/I17972996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5118144209","display_name":"Digvijay Singh Rajawat","orcid":"https://orcid.org/0009-0006-4932-2539","observed_orcids":["https://orcid.org/0009-0006-4932-2539"]},"institutions":[{"id":"https://openalex.org/I4405266460","display_name":"All India Institute of Medical Sciences, Patna","ror":"https://ror.org/033ax5g32","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4405266460"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Digvijay Singh Rajawat","raw_affiliation_strings":["All India Institute of Med Sciences, Patna, Patna, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"All India Institute of Med Sciences, Patna, Patna, India","institution_ids":["https://openalex.org/I4405266460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114131521","display_name":"Smit Thakkar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Smit Thakkar","raw_affiliation_strings":["Government Med College, Jamnagar, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Government Med College, Jamnagar, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017686486","display_name":"Abhay A. Kapoor","orcid":"https://orcid.org/0009-0001-8390-5715","observed_orcids":["https://orcid.org/0009-0001-8390-5715"]},"institutions":[{"id":"https://openalex.org/I4210124530","display_name":"St. Mary Medical Center","ror":"https://ror.org/02eqphf30","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210124530"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abhay A Kapoor","raw_affiliation_strings":["St. Mary Med Cntr, Langhorne, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Mary Med Cntr, Langhorne, PA","institution_ids":["https://openalex.org/I4210124530"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112989060","display_name":"Pratima Jasti","orcid":"https://orcid.org/0000-0002-1786-9752","observed_orcids":["https://orcid.org/0000-0002-1786-9752"]},"institutions":[{"id":"https://openalex.org/I4210117092","display_name":"All India Institute of Medical Sciences Bhubaneswar","ror":"https://ror.org/029mnbn96","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210117092"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Pratima Jasti","raw_affiliation_strings":["All India Institute of Med Sciences, Bhubaneswar, Bhubaneswar, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"All India Institute of Med Sciences, Bhubaneswar, Bhubaneswar, India","institution_ids":["https://openalex.org/I4210117092"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5119967278","display_name":"Farheen Vhora","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I64157871","display_name":"B.J. Medical College","ror":"https://ror.org/0408b4j80","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I64157871"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Farheen Vhora","raw_affiliation_strings":["B.J. Med College, Ahmedabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"B.J. Med College, Ahmedabad, India","institution_ids":["https://openalex.org/I64157871"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038181640","display_name":"Ritu Yadav","orcid":"https://orcid.org/0000-0002-5608-8617","observed_orcids":["https://orcid.org/0000-0002-5608-8617"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ritu Yadav","raw_affiliation_strings":["Midwestern Univ, Cottonwood, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Midwestern Univ, Cottonwood, AZ","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"154","issue":"Suppl_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.008700000122189522,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11763","display_name":"Intracerebral and Subarachnoid Hemorrhage Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rivaroxaban","display_name":"rivaroxaban","score":1.0},{"id":"https://openalex.org/keywords/intracranial-hemorrhage","display_name":"intracranial hemorrhage","score":0.9959999918937683},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.8460000157356262},{"id":"https://openalex.org/keywords/asian-populations","display_name":"Asian populations","score":0.6029999852180481},{"id":"https://openalex.org/keywords/hemorrhagic-stroke","display_name":"hemorrhagic stroke","score":0.8019999861717224},{"id":"https://openalex.org/keywords/cerebral-hemorrhage","display_name":"cerebral hemorrhage","score":0.8690000176429749},{"id":"https://openalex.org/keywords/anticoagulants","display_name":"anticoagulants","score":0.7450000047683716},{"id":"https://openalex.org/keywords/disproportionality-analysis","display_name":"disproportionality analysis","score":0.6499999761581421},{"id":"https://openalex.org/keywords/fda-adverse-event-reporting-system","display_name":"FDA Adverse Event Reporting System","score":0.781000018119812},{"id":"https://openalex.org/keywords/safety-signals","display_name":"safety signals","score":0.4569999873638153},{"id":"https://openalex.org/keywords/regional-sensitivity-analysis","display_name":"regional sensitivity analysis","score":0.5870000123977661},{"id":"https://openalex.org/keywords/comparative-drug-safety","display_name":"drug safety comparison","score":0.5299999713897705},{"id":"https://openalex.org/keywords/real-world-safety-data","display_name":"real-world safety data","score":0.4300000071525574}],"concepts":[{"id":"https://openalex.org/C2780290652","wikidata":"https://www.wikidata.org/wiki/Q21011234","display_name":"Edoxaban","level":5,"score":0.9916999936103821},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9732000231742859},{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.8690999746322632},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4699999988079071},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4180000126361847},{"id":"https://openalex.org/C2777094939","wikidata":"https://www.wikidata.org/wiki/Q1368943","display_name":"Intracerebral hemorrhage","level":3,"score":0.40860000252723694},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.40459999442100525},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.4009999930858612},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.3774999976158142},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.36059999465942383},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.3009999990463257},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.29440000653266907},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.2881999909877777},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.2849999964237213},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.2784999907016754},{"id":"https://openalex.org/C143095724","wikidata":"https://www.wikidata.org/wiki/Q515895","display_name":"Odds","level":3,"score":0.2757999897003174},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.2718000113964081},{"id":"https://openalex.org/C197636746","wikidata":"https://www.wikidata.org/wiki/Q7234359","display_name":"Postmarketing surveillance","level":3,"score":0.2718000113964081},{"id":"https://openalex.org/C2779668873","wikidata":"https://www.wikidata.org/wiki/Q6693756","display_name":"Lower risk","level":3,"score":0.2590000033378601},{"id":"https://openalex.org/C2777105317","wikidata":"https://www.wikidata.org/wiki/Q4686710","display_name":"Adverse Event Reporting System","level":3,"score":0.2517000138759613}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1161/circ.154.suppl_1.7110","doi":"https://doi.org/10.1161/circ.154.suppl_1.7110","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circ.154.suppl_1.7110","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2942605665","https://openalex.org/W1789003475","https://openalex.org/W2522112402","https://openalex.org/W1681417486","https://openalex.org/W2886106988","https://openalex.org/W2170189969","https://openalex.org/W2283992568","https://openalex.org/W2906512981","https://openalex.org/W4280596972","https://openalex.org/W4409527325"],"abstract_inverted_index":{"Background:":[0],"East":[1],"Asian":[2,76,140,202,229,277],"populations":[3,143,300],"exhibit":[4],"a":[5,84,114,231,256,272],"paradoxically":[6],"higher":[7,236],"susceptibility":[8],"to":[9,42,55,135,246],"intracranial":[10,44,57,118,183,262],"hemorrhage":[11,45,58,263],"(ICH)":[12],"compared":[13,185,212,264],"with":[14,177,186,213,228,265],"Western":[15],"cohorts.":[16],"While":[17],"Edoxaban":[18,48,61,97,156,171,174,210,226,254],"is":[19],"widely":[20],"prescribed":[21],"in":[22,75,164,299],"Asia":[23],"because":[24],"of":[25,113,139,182,198,208,216,224,261,276,289],"its":[26],"favorable":[27,244,268],"safety":[28,69,146,241,292],"profile,":[29],"comparative":[30],"real-world":[31,252],"data":[32],"versus":[33,141,169],"Rivaroxaban":[34,63,99,153,166,187,218],"regarding":[35],"cerebrovascular":[36,291],"bleeding":[37,184],"remain":[38],"limited.":[39],"We":[40,53,82,95],"aimed":[41],"compare":[43,56],"reporting":[46,59,180,259],"between":[47,60,294],"and":[49,62,64,98,122,154],"Rivaroxaban.":[50,247,266],"Research":[51],"Question:":[52],"sought":[54],"evaluate":[65],"whether":[66],"the":[67,88,108,137,145,195,209,217,225,239],"observed":[68],"signal":[70,242,269],"remained":[71,243],"evident":[72],"despite":[73,271],"differences":[74,293],"representation":[77,138],"among":[78,279],"reported":[79,280],"cases.":[80,283],"Methods:":[81],"conducted":[83],"disproportionality":[85],"analysis":[86,128,150],"using":[87],"FDA":[89],"Adverse":[90],"Event":[91],"Reporting":[92,109],"System":[93],"(FAERS).":[94],"queried":[96],"as":[100],"primary":[101,105],"suspect":[102],"drugs.":[103],"The":[104,149,158],"endpoint":[106,116,161],"was":[107,162,175],"Odds":[110],"Ratio":[111],"(ROR)":[112],"composite":[115,159],"comprising":[117],"hemorrhage,":[119,121],"cerebral":[120],"hemorrhagic":[123,237,303],"stroke.":[124],"A":[125],"regional":[126,196],"sensitivity":[127],"stratified":[129],"event":[130],"cases":[131,167,172],"by":[132],"reporter":[133],"country":[134],"assess":[136],"non-Asian":[142],"within":[144],"signal.":[147],"Results:":[148],"included":[151],"147,541":[152],"1,255":[155],"reports.":[157],"ICH":[160,200,282],"identified":[163],"6,918":[165],"(4.69%)":[168],"39":[170],"(3.11%).":[173],"associated":[176],"significantly":[178],"lower":[179,258],"odds":[181,260],"(ROR:":[188],"0.65;":[189],"95%":[190],"CI:":[191],"0.47-0.90;":[192],"p=0.01).":[193],"In":[194,249],"sub-analysis":[197],"confirmed":[199],"cases,":[201],"patients":[203,278],"accounted":[204],"for":[205],"30.8%":[206],"(12/39)":[207],"cohort":[211],"4.3%":[214],"(296/6,918)":[215],"cohort.":[219],"Despite":[220],"this":[221,250],"substantial":[222],"enrichment":[223],"group":[227],"patients,":[230],"population":[232],"historically":[233],"considered":[234],"at":[235,301],"risk,":[238],"overall":[240],"relative":[245],"Conclusion:":[248],"large-scale":[251],"analysis,":[253],"demonstrated":[255],"35%":[257],"This":[267],"persisted":[270],"sevenfold":[273],"greater":[274],"proportion":[275],"Edoxaban-associated":[281],"These":[284],"findings":[285],"support":[286],"further":[287],"investigation":[288],"potential":[290],"factor":[295],"Xa":[296],"inhibitors,":[297],"particularly":[298],"elevated":[302],"risk.":[304]},"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-11-09T00:00:00"}